Asker Healthcare Group has started 2026 with another proposed acquisition, signing an agreement to acquire German Healthcare and Medicalprodukte Vertrieb Flensburg (GHC/MPF), two interlinked medical supplies companies within the homecare segment in Germany.
The acquisition of GHC/MPF conforms with Asker’s ambition to grow within the homecare segment in Germany.
“The company...
Insilico Medicine, a clinical-stage drug discovery and development company, listed on the Hong Kong Stock Exchange at the end of December, becoming the first AI-driven biotech company to go public on the exchange’s Main Board. The IPO raised a total of HKD2.277bn (US$292m).
Insilico's listing, jointly sponsored by Morgan Stanley, CICC and GF Securities, attracted strong interest from local and international investors. A total of 94,690,500 shares were offered globally, with 10% Hong Kong public offering, which was oversubscribed by approximately 1427.37 times, locking in subscription funds of over HKD328.349bn....
